Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.1 (
phosphodiesterase
)
18,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The cardiolipin
phosphodiesterase
of Escherichia coli was further characterized. This enzyme has a pH optimum of 7.0 and is Mg2+ dependent. Mn2+ and Co2+ could replace Mg2+ but other divalent cations were inhibitory or without effect. The enzyme is not periplasmic and does not appear to be associated with membrane fractions prepared by different methods. It is recovered as a soluble protein in the cytosol fraction but could not be readily purified because of its instability. With cell-free systems, a requirement for ATP or ADP could be shown under certain defined conditions. Other nucleotides were less effective or ineffective in stimulating the
phosphodiesterase
. The cells displayed the highest activity during the middle to late exponential stage but no marked requirement for ATP was apparent when the
phosphodiesterase
was obtained from such freshly grown cells. If, however, cells were starved for several hours in saline medium, the cardiolipin
phosphodiesterase
level fell and a requirement for added ATP could be shown. The cardiolipin
phosphodiesterase
is an enzyme distinct from
cardiolipin synthase
. The assay conditions are quite different from each of these enzymes as are their subcellular distributions.
...
PMID:Further studies on the cardiolipin phosphodiesterase of Escherichia coli. 2 9